• News
    • Opinion Editorial
    • Videos
    • Podcasts
  • Community
    • Members
  • Discussion
  • Groups
    • View All
    • Why Join?
  • Write for us
    Sign in Sign up


    • News
      • Opinion Editorial
      • Videos
      • Podcasts
    • Community
      • Members
    • Discussion
    • Groups
      • View All
      • Why Join?
    • Write for us
    Sign in Sign up

    Tag: Regenerative Medicine

    Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

    Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

    Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into an…

    TrialSite Staff
    TrialSite Staff April 14, 2021
    1 Comment
    Ohio State University Regenerative Therapy Targeting Ischemic Stroke Shows Positive Preclinical Results

    Ohio State University Regenerative Therapy Targeting Ischemic Stroke Shows Positive Preclinical Results

    Research scientists from Ohio State University are in hot pursuit of a regenerative therapy solution for ischemic stroke. By injecting a stem cell-based treatment, they…

    TrialSite Staff
    TrialSite Staff March 23, 2021
    0 Comments
    Cell and Gene Therapy Venture Financing Explodes as Belgium-based AgomAb Receives $74m B Series

    Cell and Gene Therapy Venture Financing Explodes as Belgium-based AgomAb Receives $74m B Series

    Financing in the regenerative medicine biotech market, especially for those firms developing cell and gene therapies, absolutely explodes as last year global financing for companies…

    TrialSite Staff
    TrialSite Staff March 17, 2021
    0 Comments
    Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers

    Icahn School of Medicine Cardiovascular Regenerative Therapy Investigator Receives $2.9m to Investigate Stem Cell Regenerative Powers

    The potential of regenerative therapies will be explored thanks to a recently announced $2.9 million grant from the National Institutes of Health (NIH) investigating the…

    TrialSite Staff
    TrialSite Staff November 26, 2020
    0 Comments
    Physician in Savannah Georgia Embraces Investigational Regenerative Acellular-based Therapy to Treat COVID-19 Long Haulers on FDA Expanded Access Protocol

    Physician in Savannah, Georgia, Embraces Investigational Regenerative Acellular-based Therapy to Treat COVID-19 Long Haulers on FDA Expanded Access Protocol

    With over 12 million COVID-19 cases and growing, some physicians become ever more open and innovative in their quest to treat their patients. Take Dr. Allen…

    TrialSite Staff
    TrialSite Staff November 25, 2020
    0 Comments
    Novartis Pays $50m Upfront Cash for License and Stock in Mesoblast to Access Mesenchymal Stromal Cells Regenerative Therapy Platform

    Novartis Pays $50m Upfront Cash for License and Stock in Mesoblast to Access Mesenchymal Stromal Cells Regenerative Therapy Platform

    Novartis recently inked an exclusive worldwide license and collaboration agreement with regenerative therapy venture Mesoblast to develop, commercialize and manufacture remestemcel-L for the treatment of…

    TrialSite Staff
    TrialSite Staff November 20, 2020
    1 Comment
    Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer

    Hackensack University Medical Center Offers Clinical Trial to Investigate Nerve Recovery Post Robotic Prostatectomy for Prostate Cancer

    Hackensack Meridian Hackensack University Medical Center’s Department of Urology is among the first in the nation to embrace bioregenerative medicine as a new way to promote…

    TrialSite Staff
    TrialSite Staff October 11, 2020
    0 Comments
    Seattle’s IDRI & Celularity Launch Phase 12 Clinical Trial Investigating Natural Killer Cells Targeting COVID-19

    Seattle’s IDRI & Celularity Launch Phase 1/2 Clinical Trial Investigating Natural Killer Cells Targeting COVID-19

    Can advanced, cellular-based immunotherapy investigational therapies take out COVID-19 in hospitalized patients? Seattle’s Infectious Disease Research Institute (IDRI) along with study sponsor Celularity are conducting…

    TrialSite Staff
    TrialSite Staff September 11, 2020
    0 Comments
    Children’s Hospital Los Angeles Investigators Secure $4m for Regenerative Research & Cell Therapeutics

    Children’s Hospital Los Angeles Investigators Secure $4m for Regenerative Research & Cell Therapeutics

    Two prominent researchers from the Saban Research Institute of Children’s Hospital Los Angeles haves secured over $4 million from the National Institute of Diabetes and…

    TrialSite Staff
    TrialSite Staff August 26, 2020
    0 Comments
    What are Next Generation Exosome Therapeutics A Conversation with Organicell

    What are Next Generation Exosome Therapeutics? A Conversation with Organicell

    Back in May, TrialSite reported that Landmark Hospital, a group of long-term acute care hospitals across the southeastern United States, announced its decision to study an investigational…

    TrialSite Staff
    TrialSite Staff August 19, 2020
    0 Comments
    Load More

    Read more about…

    Alzheimer Alzheimer's Disease Artificial Intelligence Autoimmune Disease Breast Cancer Cancer Cardiovascular Challenging Results China Clinical Research Clinical Research as a Care Option Clinical Trials CNS Coronavirus covid-19 COVID-19 Dementia Diabetes Digital Health Digital Media FDA Gene Therapy Immunotherapy India Investigator Content Investigator Profiles Investor Watch Ivermectin Leading Pharma Leading Sites Neurology NIH Oncology Patient Recruitment Pharma Watch Positive Results Price Watch Prostate Cancer Research SARS-CoV-2 Site Challenges Site Success Site Watch UK Vaccine

    About Us

    TRIALSITE NEWS IS  DEDICATED TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

    © 2021 - Trial Site News
    • Terms of Service
    • Privacy Policy

    TrialSite News
    159 W Broadway, Suite 200
    Salt Lake City, UT 84101

    Report Content

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Anything overly promotional selling products or services

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Invite this member to groups
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.